Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03866382 |
Recruitment Status :
Recruiting
First Posted : March 7, 2019
Last Update Posted : April 19, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Bladder Adenocarcinoma Bladder Clear Cell Adenocarcinoma Bladder Mixed Adenocarcinoma Bladder Neuroendocrine Carcinoma Bladder Small Cell Neuroendocrine Carcinoma Bladder Squamous Cell Carcinoma Bladder Urachal Adenocarcinoma Chromophobe Renal Cell Carcinoma Collecting Duct Carcinoma Infiltrating Bladder Lymphoepithelioma-Like Carcinoma Infiltrating Bladder Urothelial Carcinoma Infiltrating Bladder Urothelial Carcinoma With Giant Cells Infiltrating Bladder Urothelial Carcinoma, Nested Variant Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant Kidney Medullary Carcinoma Large Cell Neuroendocrine Carcinoma Metastatic Bladder Carcinoma Metastatic Bladder Large Cell Neuroendocrine Carcinoma Metastatic Bladder Small Cell Neuroendocrine Carcinoma Metastatic Bladder Squamous Cell Carcinoma Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant Metastatic Kidney Medullary Carcinoma Metastatic Malignant Genitourinary System Neoplasm Metastatic Penile Carcinoma Metastatic Prostate Small Cell Neuroendocrine Carcinoma Metastatic Sarcomatoid Renal Cell Carcinoma Metastatic Urethral Carcinoma Papillary Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma Stage IV Bladder Cancer AJCC v8 Stage IV Penile Cancer AJCC v8 Stage IV Prostate Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8 Stage IV Urethral Cancer AJCC v8 Stage IVA Bladder Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Bladder Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8 Testicular Leydig Cell Tumor Testicular Sertoli Cell Tumor Urethral Clear Cell Adenocarcinoma | Drug: Cabozantinib S-malate Biological: Ipilimumab Biological: Nivolumab | Phase 2 |
PRIMARY OBJECTIVE:
I. To evaluate the efficacy of cabozantinib s-malate (cabozantinib) combined with nivolumab and ipilimumab in the first or second-line (and beyond) setting for patients within each of the rare genitourinary (GU) variant histology group of interest, as measured by objective response rate (ORR).
SECONDARY OBJECTIVES:
I. To estimate the progression-free survival (PFS) for patients treated with cabozantinib combined with nivolumab and ipilimumab within each rare variant histology.
II. To estimate the overall survival (OS) for patients treated with cabozantinib combined with nivolumab and ipilimumab within each rare variant histology.
III. To estimate the clinical benefit rate (defined as complete response [CR] or partial response [PR] or stable disease [SD]) for patients treated with cabozantinib combined with nivolumab and ipilimumab within each rare variant histology.
IV. To assess the safety of treating patients with rare variant histologies with cabozantinib combined with nivolumab and ipilimumab.
V. To support tissue banking and collection of clinical follow-up data for GU tract rare histological variants.
EXPLORATORY OBJECTIVES:
I. To assess effects of treatment in patients with bone-only disease by bone scan.
OUTLINE:
Patients receive cabozantinib orally (PO) once daily (QD) on days 1-21 of cycles 1-4 and on days 1-28 of subsequent cycles. Patients also receive nivolumab intravenously (IV) over 30 minutes on day 1 and ipilimumab IV over 90 minutes on day 1 of cycles 1-4. Patients then receive nivolumab IV over 30 minutes on day 1 of subsequent cycles. Treatment repeats every 21 days for cycles 1-4 and every 28 days for subsequent cycles for 2 years in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 2 months for 5 years.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 224 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC) |
Actual Study Start Date : | April 12, 2019 |
Estimated Primary Completion Date : | February 28, 2023 |
Estimated Study Completion Date : | February 28, 2023 |

Arm | Intervention/treatment |
---|---|
Experimental: Treatment (cabozantinib, nivolumab, ipilimumab)
Patients receive cabozantinib PO QD on days 1-21 of cycles 1-4 and on days 1-28 of subsequent cycles. Patients also receive nivolumab IV over 30 minutes on day 1 and ipilimumab IV over 90 minutes on day 1 of cycles 1-4. Patients then receive nivolumab IV over 30 minutes on day 1 of subsequent cycles. Treatment repeats every 21 days for cycles 1-4 and every 28 days for subsequent cycles for 2 years in the absence of disease progression or unacceptable toxicity.
|
Drug: Cabozantinib S-malate
Given PO
Other Names:
Biological: Ipilimumab Given IV
Other Names:
Biological: Nivolumab Given IV
Other Names:
|
- Objective response rate (ORR) [ Time Frame: Up to 5 years ]An objective response is defined as a confirmed complete response (CR) or partial response (PR) as assessed by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. A confirmed tumor response is defined to be either a CR or PR noted as the objective status on 2 consecutive evaluations at least 4 weeks apart. Will be estimated by the number of confirmed objective responses divided by the total number of evaluable patients. Confidence intervals for the true ORR will be calculated.
- Duration of response [ Time Frame: From time measurement criteria are met for CR or PR (whichever is first recorded) until the first date that recurrent or progressive disease is objectively documented, assessed up to 5 years ]Defined for all evaluable patients who have achieved an objective response as the date at which the patient's earliest best objective status is first noted to be either a CR or PR to the earliest date progression is documented.
- Progression-free survival (PFS) [ Time Frame: From start of treatment to time of progression or death, whichever occurs first, assessed up to 5 years ]The median its 95% confidence interval will be determined and will be summarized using the Kaplan-Meier estimator.
- Overall survival [ Time Frame: Up to 5 years ]The median its 95% confidence interval will be determined and will be summarized using the Kaplan-Meier estimator.
- Clinical benefit rate (CBR) [ Time Frame: Up to 5 years ]A confirmed clinical benefit is defined to be either a CR or PR noted as the objective status on 2 consecutive evaluations at least 4 weeks apart or a confirmed stable disease at two consecutive tumor assessments at least 3 months apart. The CBR will be estimated by the number of patients with confirmed clinical benefit divided by the total number of evaluable patients. Confidence intervals for the true CBR will be calculated using exact binomial confidence intervals.
- Incidence of adverse events (AE) [ Time Frame: Up to 5 years ]Will be assessed using Common Terminology Criteria for Adverse Events version 5.0. The maximum of a particular AE will be determined for each patient. Tables will summarize the number and relative frequency of patients observing an AE as well as the number and relative frequency of patients experiencing any AE of grade 3 or greater.
- Effects of treatment in patients with bone-only disease [ Time Frame: Up to 5 years ]The bone-only tumor patients will be evaluated in an exploratory fashion (if no RECIST measurements are available). A maximum of 15 patients with bone-only disease will be enrolled and evaluated using PFS for a descriptive analysis of the effect of treatment.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
-
Metastatic disease defined as new or progressive lesions on cross-sectional imaging or bone scan. Patients must have at least:
- One measurable site of disease as per Response Evaluation Criteria in Solid Tumors (RECIST) version (v) 1.1
- One bone lesion on bone scan (tec99 or sodium fluoride [NaF] positron emission tomography [PET]/computed tomography [CT], CT, or magnetic resonance imaging [MRI]) for the bone-only cohort
-
Histologically confirmed diagnosis of one of the following metastatic cohorts:
- Small cell/ neuroendocrine carcinoma of the bladder - All urothelial carcinomas with any amount of neuroendocrine differentiation (including small cell differentiation) will be included. If the tumor is purely neuroendocrine, metastasis from another site of origin should be clinically excluded.
- Adenocarcinoma of the bladder, or urachal adenocarcinoma, or bladder/urethra clear cell adenocarcinoma - must be pure (per World Health Organization [WHO] definition), (i.e. urothelial carcinoma with glandular differentiation is not considered a pure adenocarcinoma.
- Squamous cell carcinoma of the bladder - must be pure (i.e. urothelial carcinoma with squamous differentiation is not considered a pure squamous cell carcinoma).
- Plasmacytoid urothelial carcinoma - Tumor should show predominantly > or equal ~50% plasmacytoid histology (including all types of discohesive growth, such as tumors with signet-ring and/or rhabdoid features as well).
- Any penile cancer
- Sarcomatoid renal cell carcinoma - Tumor should be predominantly sarcomatoid ~50% (including rhabdoid differentiation) is also unclassified renal cell carcinomas (RCCs): all (assuming they are high grade with metastasis) malignant angiomyolipomas are allowed.
- Sarcomatoid urothelial carcinoma - Tumor should show predominantly ~ 50% sarcomatoid differentiation.
- Renal medullary carcinoma - Per WHO definition, ideally confirmed with immunostains.
- Renal collecting duct carcinoma - Per WHO definition (medullary involvement, predominant tubular morphology, desmoplastic stromal reaction, high grade cytology, infiltrative growth pattern, and absence of other renal cell carcinoma subtype or urothelial carcinoma).
- Bone only urothelial carcinoma or other non-prostate GU tumor
- Urethra carcinoma - May be of any histology but if urothelial carcinoma then must be isolated to the urethra and not have metachronous or synchronous urothelial carcinoma of the bladder.
-
Other miscellaneous histologic variants of the urothelial carcinoma, such as, but not limited to: micropapillary (Tumor should show predominantly > or equal 50% micropapillary architecture), giant cell, lipid-rich, clear cell and nested variants (Tumor should predominantly > or equal 50% show these features), large cell neuroendocrine carcinoma, lymphoepithelioma-like carcinoma and mixed patterns will be considered, as well as small cell neuroendocrine prostate cancer (Only treatment-naïve primary small cell of prostate with any amount of small cell component allowed. Post-treatment small cell prostatic carcinomas are not allowed), Malignant testicular Sertoli or Leydig cell tumors, and papillary and chromophobe RCC.
- Note: Translocation positive renal cell carcinoma patients are eligible. However, AREN1721 should be considered before this trial.
- Hematoxylin and eosin (H&E) slides from diagnostic tumor tissue for retrospective central pathology review
- Patients may have received up to 2 systemic anti-cancer treatments or be treatment naive. Patients with small cell carcinoma should have received a platinum-based combination regimen either as neoadjuvant, adjuvant or first-line treatment). Patients in the bone-only cohort may be urothelial carcinoma histology but must receive standard cisplatin-based chemotherapy (if cisplatin-eligible).
- Patients must be able to swallow oral formulation of the tablets
- Karnofsky performance status >= 80%
- Absolute neutrophil count (ANC) >= 1,000/mcL
- Platelet count >= 75,000/mcL
- Total bilirubin =< 1.5 x upper limit of normal (ULN). For subjects with known Gilbert's disease or similar syndrome with slow conjugation of bilirubin, total bilirubin =< 3.0 mg/dL
- Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< 3.0 x institutional upper limit of normal (ULN) (or =< 5 x ULN for patients with liver metastases or Gilbert's disease)
- Creatinine =< 1.5 x upper limit of normal (ULN) OR creatinine clearance >= 40 mL/min/1.73 m^2 (calculated using the Chronic Kidney Disease Epidemiology [CKD-EPI] equation or Cockcroft-Gault formula) for patients with creatinine levels above institutional normal
- Hemoglobin >= 9 g/dL (transfusion of packed red blood cells [PRBCs] allowed)
- Serum albumin >= 3.2 g/dL
- Lipase and amylase =< 2.0 x ULN and no radiologic (on baseline anatomical imaging) or clinical evidence of pancreatitis
- Prior treatment with MET or VEGFR inhibitors is allowed. However, prior cabozantinib will not be allowed. Also, patients that have received both prior MET or VEGF and prior PD-1/PD-L1/CTLA-4 (sequentially or in combination) are also not allowed
- Prior treatment with any therapy on the PD-1/PD-L1 axis or anti- CTLA-4/CTLA-4 inhibitors is allowed, either in the perioperative or in the metastatic setting. However, patients that have received both prior MET or VEGF and prior PD-1/PD-L1/CTLA-4 (sequentially or in combination) are not allowed
- Human immunodeficiency virus (HIV)-positive patients are eligible if on stable dose of highly active antiretroviral therapy (HAART), no clinically significant drug-drug interactions are anticipated with the current HAART regimen, CD4 counts are greater than 350 and viral load is undetectable
- Patients with rheumatoid arthritis and other rheumatologic arthropathies, Sjogren's syndrome and psoriasis controlled with topical medication only and patients with positive serology, such as antinuclear antibodies (ANA), anti-thyroid antibodies etc. are eligible but should be considered for rheumatologic evaluation for the presence of target organ involvement and potential need for systemic treatment
- Patients with vitiligo, endocrine deficiencies including thyroiditis managed with replacement hormones or medications (e.g. thyroiditis managed with propylthiouracil [PTU] or methimazole) including physiologic oral corticosteroids are eligible
- Patients who have evidence of active or acute diverticulitis, intra-abdominal abscess, and gastrointestinal (GI) obstruction, within 12 months are not eligible
-
Women of childbearing potential must have a negative pregnancy test =< 7 days prior to registration
- Women of childbearing potential include women who have experienced menarche and who have not undergone successful surgical sterilization (hysterectomy, bilateral tubal ligation, or bilateral oophorectomy) or are not postmenopausal. Post menopause is defined as amenorrhea >= 12 consecutive months. Note: women who have been amenorrheic for 12 or more months are still considered to be of childbearing potential if the amenorrhea is possibly due to prior chemotherapy, antiestrogens, ovarian suppression or any other reversible reason
- Pregnant women may not participate in this study because with cabozantinib, nivolumab, and ipilimumab have potential for teratogenic or abortifacient effects. Because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with cabozantinib, nivolumab, and ipilimumab, breastfeeding should be discontinued if the mother is treated with these agents
- The patient has received no cytotoxic chemotherapy (including investigational cytotoxic chemotherapy) or biologic agents (e.g., cytokines or antibodies) within 2 weeks before the first dose of study treatment
-
The patient has received no radiation therapy:
- To the lungs and mediastinum or abdomen within 4 weeks before the first dose of study treatment, or has ongoing complications, or is healing from prior radiation therapy
- To brain metastasis within 3 weeks for whole-brain radiotherapy (WBXRT), and 2 weeks for stereotactic body radiation therapy (SBRT) before the first dose of study treatment
- To the abdomen within 4 weeks before the first dose of study treatment, or has ongoing complications, or is healing from prior radiation therapy
- To any other site(s) within 2 weeks before the first dose of study treatment
- The patient has received no radionuclide treatment within 6 weeks of the first dose of study treatment
- The patient has received no prior treatment with a small molecule kinase inhibitor within 14 days or five half-lives of the compound or active metabolites, whichever is longer, before the first dose of study treatment
- The patient has received no prior treatment with hormonal therapy within 14 days or five half-lives of the compound or active metabolites, whichever is longer, before the first dose of study treatment. Subjects receiving gonadotropin-releasing hormone (GnRH) agonists and antagonists are allowed to participate
- The patient has not received any other type of investigational agent within 14 days before the first dose of study treatment
- The patient must have recovered to baseline or Common Terminology Criteria for Adverse Events (CTCAE) =< grade 1 from toxicity due to all prior therapies except alopecia, neuropathy and other non-clinically significant adverse events (AEs) defined as lab elevation with no associated symptoms or sequelae
- The patient may not have active brain metastases or epidural disease. Patients with brain metastases previously treated with whole brain radiation or radiosurgery who are asymptomatic and do not require steroid treatment for at least 2 weeks before starting study treatment are eligible. Neurosurgical resection of brain metastases or brain biopsy is permitted if completed at least 3 months before starting study treatment. Baseline brain imaging with contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI) scans for subjects with known brain metastases is required to confirm eligibility
- No concomitant treatment with warfarin. Aspirin (up to 325 mg/day), thrombin or factor Xa inhibitors, low-dose warfarin (=< 1 mg/day), prophylactic and therapeutic low molecular weight heparin (LMWH) are permitted
-
No chronic concomitant treatment with strong CYP3A4 inducers (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentine, phenobarbital, and St. John's wort) or strong CYP3A4 inhibitors
- Because the lists of these agents are constantly changing, it is important to regularly consult medical reference texts such as the Physicians' Desk Reference may also provide this information. As part of the enrollment/informed consent procedures, the patient will be counseled on the risk of interactions with other agents, and what to do if new medications need to be prescribed or if the patient is considering a new over-the-counter medicine or herbal product
-
The patient has not experienced any of the following:
- Clinically-significant gastrointestinal bleeding within 6 months before the first dose of study treatment
- Hemoptysis of >= 0.5 teaspoon (2.5 mL) of red blood per day within 1 months before the first dose of study treatment
- Any other signs indicative of pulmonary hemorrhage within 3 months before the first dose of study treatment
- The patient has no tumor invading any major blood vessels
- The patient has no evidence of tumor invading the GI tract (esophagus, stomach, small or large bowel, rectum or anus), or any evidence of endotracheal or endobronchial tumor within 28 days before the first dose of cabozantinib. Patients with rectal tumor masses are not eligible.
-
The patient has no uncontrolled, significant intercurrent or recent illness including, but not limited to, the following conditions:
-
Cardiovascular disorders including:
- Congestive heart failure (CHF): New York Heart Association (NYHA) class III (moderate) or class IV (severe) at the time of screening.
- Concurrent uncontrolled hypertension defined as sustained blood pressure (BP) > 150 mm Hg systolic, or > 90 mm Hg diastolic despite optimal antihypertensive treatment within 7 days of the first dose of study treatment
- The subject has a corrected QT interval calculated by the Fridericia formula (QTcF) > 500 ms within 28 days before randomization. Note: if initial QTcF is found to be > 500 ms, two additional electrocardiograms (EKGs) separated by at least 3 minutes should be performed. If the average of these three consecutive results for QTcF is =< 500 ms, the subject meets eligibility in this regard
- Any history of congenital long QT syndrome
-
Any of the following within 6 months before registration of study treatment:
- Unstable angina pectoris
- Clinically-significant cardiac arrhythmias (patients with atrial fibrillation are eligible)
- Stroke (including transient ischemic attack [TIA], or other ischemic event)
- Myocardial infarction
- Cardiomyopathy
-
No significant gastrointestinal disorders particularly those associated with a high risk of perforation or fistula formation including:
-
Any of the following that have not resolved within 28 days before the first dose of study treatment:
- Active peptic ulcer disease
- Acute diverticulitis, cholecystitis, symptomatic cholangitis or appendicitis, or malabsorption syndrome
-
None of the following within 2 years before the first dose of study treatment:
- Abdominal fistula or genitourinary fistula
- Gastrointestinal perforation
- Bowel obstruction or gastric outlet obstruction
- Intra-abdominal abscess. Note: Complete resolution of an intra-abdominal abscess must be confirmed prior to initiating treatment with cabozantinib even if the abscess occurred more than 2 years before the first dose of study treatment
-
- Disorders associated with a high risk of fistula formation including percutaneous endoscopic gastrostomy (PEG) tube placement are not eligible
-
No other clinically significant disorders such as:
- Severe active infection requiring IV systemic treatment within 14 days before the first dose of study treatment
- Serious non-healing wound/ulcer/bone fracture within 28 days before the first dose of study treatment
- History of organ or allogeneic stem cell transplant
- Concurrent uncompensated hypothyroidism or thyroid dysfunction within 7 days before the first dose of study treatment (for asymptomatic patients with an elevated thyroid-stimulating hormone [TSH], thyroid replacement may be initiated if clinically indicated without delaying the start of study treatment)
-
No history of major surgery as follows:
- Major surgery within 3 months of the first dose of ca
-

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03866382


United States, Alabama | |
University of Alabama at Birmingham Cancer Center | Recruiting |
Birmingham, Alabama, United States, 35233 | |
Contact: Site Public Contact 205-934-0220 tmyrick@uab.edu | |
Principal Investigator: Lakshminarayanan Nandagopal | |
United States, Alaska | |
Anchorage Associates in Radiation Medicine | Recruiting |
Anchorage, Alaska, United States, 98508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Anchorage Radiation Therapy Center | Recruiting |
Anchorage, Alaska, United States, 99504 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Breast Care and Surgery LLC | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Oncology and Hematology LLC | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Women's Cancer Care | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Anchorage Oncology Centre | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Katmai Oncology Group | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Alaska Medical Center | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
United States, Arizona | |
Kingman Regional Medical Center | Recruiting |
Kingman, Arizona, United States, 86401 | |
Contact: Site Public Contact 773-702-9171 protocols@AllianceNCTN.org | |
Principal Investigator: John A. Ellerton | |
Cancer Center at Saint Joseph's | Recruiting |
Phoenix, Arizona, United States, 85004 | |
Contact: Site Public Contact 602-406-8222 | |
Principal Investigator: Richard L. Deming | |
Mayo Clinic Hospital in Arizona | Recruiting |
Phoenix, Arizona, United States, 85054 | |
Contact: Site Public Contact 855-776-0015 | |
Principal Investigator: Lance C. Pagliaro | |
Mayo Clinic in Arizona | Recruiting |
Scottsdale, Arizona, United States, 85259 | |
Contact: Site Public Contact 855-776-0015 | |
Principal Investigator: Lance C. Pagliaro | |
University of Arizona Cancer Center-Orange Grove Campus | Recruiting |
Tucson, Arizona, United States, 85704 | |
Contact: Site Public Contact 520-694-8900 | |
Principal Investigator: Edward P. Gelmann | |
Banner University Medical Center - Tucson | Recruiting |
Tucson, Arizona, United States, 85719 | |
Contact: Site Public Contact aselegue@email.arizona.edu | |
Principal Investigator: Edward P. Gelmann | |
University of Arizona Cancer Center-North Campus | Recruiting |
Tucson, Arizona, United States, 85719 | |
Contact: Site Public Contact 800-327-2873 | |
Principal Investigator: Edward P. Gelmann | |
United States, Arkansas | |
Mercy Hospital Fort Smith | Recruiting |
Fort Smith, Arkansas, United States, 72903 | |
Contact: Site Public Contact 800-378-9373 | |
Principal Investigator: Jay W. Carlson | |
CHI Saint Vincent Cancer Center Hot Springs | Recruiting |
Hot Springs, Arkansas, United States, 71913 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, California | |
Mission Hope Medical Oncology - Arroyo Grande | Recruiting |
Arroyo Grande, California, United States, 93420 | |
Contact: Site Public Contact 916-851-2283 research@dignityhealth.org | |
Principal Investigator: Richard L. Deming | |
PCR Oncology | Recruiting |
Arroyo Grande, California, United States, 93420 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Providence Saint Joseph Medical Center/Disney Family Cancer Center | Recruiting |
Burbank, California, United States, 91505 | |
Contact: Site Public Contact 818-847-4793 Najee.Boucher@providence.org | |
Principal Investigator: Alison K. Conlin | |
Community Cancer Institute | Recruiting |
Clovis, California, United States, 93611 | |
Contact: Site Public Contact 559-387-1827 | |
Principal Investigator: Uzair B. Chaudhary | |
University Oncology Associates | Recruiting |
Clovis, California, United States, 93611 | |
Contact: Site Public Contact 559-256-9680 | |
Principal Investigator: Uzair B. Chaudhary | |
Epic Care-Dublin | Recruiting |
Dublin, California, United States, 94568 | |
Contact: Site Public Contact 925-875-1677 | |
Principal Investigator: Lisa Bailey | |
Bay Area Breast Surgeons Inc | Recruiting |
Emeryville, California, United States, 94608 | |
Contact: Site Public Contact 510-835-9900 | |
Principal Investigator: Lisa Bailey | |
Epic Care Partners in Cancer Care | Recruiting |
Emeryville, California, United States, 94608 | |
Contact: Site Public Contact 510-629-6682 | |
Principal Investigator: Lisa Bailey | |
Marin Cancer Care Inc | Recruiting |
Greenbrae, California, United States, 94904 | |
Contact: Site Public Contact 415-925-5000 info@marinspecialtycare.com | |
Principal Investigator: Peter D. Eisenberg | |
Los Angeles County-USC Medical Center | Recruiting |
Los Angeles, California, United States, 90033 | |
Contact: Site Public Contact 323-865-0451 | |
Principal Investigator: Anishka D'Souza | |
USC / Norris Comprehensive Cancer Center | Recruiting |
Los Angeles, California, United States, 90033 | |
Contact: Site Public Contact 323-865-0451 | |
Principal Investigator: Anishka D'Souza | |
UCLA / Jonsson Comprehensive Cancer Center | Recruiting |
Los Angeles, California, United States, 90095 | |
Contact: Site Public Contact 888-798-0719 | |
Principal Investigator: Sandy T. Liu | |
Contra Costa Regional Medical Center | Recruiting |
Martinez, California, United States, 94553-3156 | |
Contact: Site Public Contact 925-957-5400 | |
Principal Investigator: Lisa Bailey | |
USC Norris Oncology/Hematology-Newport Beach | Recruiting |
Newport Beach, California, United States, 92663 | |
Contact: Site Public Contact 323-865-0451 | |
Principal Investigator: Anishka D'Souza | |
Alta Bates Summit Medical Center - Summit Campus | Recruiting |
Oakland, California, United States, 94609 | |
Contact: Site Public Contact 510-204-1414 | |
Principal Investigator: Lisa Bailey | |
Bay Area Tumor Institute | Recruiting |
Oakland, California, United States, 94609 | |
Contact: Site Public Contact 510-465-2242 lradke@bati.org | |
Principal Investigator: Lisa Bailey | |
Pacific Central Coast Health Center-San Luis Obispo | Recruiting |
San Luis Obispo, California, United States, 93401 | |
Contact: Site Public Contact Diane.DeVos-Schmidt@DignityHealth.org | |
Principal Investigator: Richard L. Deming | |
Mission Hope Medical Oncology - Santa Maria | Recruiting |
Santa Maria, California, United States, 93444 | |
Contact: Site Public Contact 916-851-2283 research@dignityhealth.org | |
Principal Investigator: Richard L. Deming | |
Epic Care Cyberknife Center | Recruiting |
Walnut Creek, California, United States, 94597 | |
Contact: Site Public Contact 510-465-8016 somega@bati.org | |
Principal Investigator: Lisa Bailey | |
United States, Colorado | |
Penrose-Saint Francis Healthcare | Recruiting |
Colorado Springs, Colorado, United States, 80907 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Penrose | Recruiting |
Colorado Springs, Colorado, United States, 80907 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Richard L. Deming | |
Porter Adventist Hospital | Recruiting |
Denver, Colorado, United States, 80210 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Medical Center | Recruiting |
Durango, Colorado, United States, 81301 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Southwest Oncology PC | Recruiting |
Durango, Colorado, United States, 81301 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Anthony Hospital | Recruiting |
Lakewood, Colorado, United States, 80228 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Littleton Adventist Hospital | Recruiting |
Littleton, Colorado, United States, 80122 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Longmont United Hospital | Recruiting |
Longmont, Colorado, United States, 80501 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Longmont | Recruiting |
Longmont, Colorado, United States, 80501 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Richard L. Deming | |
Parker Adventist Hospital | Recruiting |
Parker, Colorado, United States, 80138 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Mary Corwin Medical Center | Recruiting |
Pueblo, Colorado, United States, 81004 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, District of Columbia | |
MedStar Georgetown University Hospital | Recruiting |
Washington, District of Columbia, United States, 20007 | |
Contact: Site Public Contact 202-444-2223 | |
Principal Investigator: Nancy A. Dawson | |
United States, Florida | |
Mount Sinai Comprehensive Cancer Center at Aventura | Recruiting |
Aventura, Florida, United States, 33180 | |
Contact: Site Public Contact 305-674-2625 yenrique@msmc.com | |
Principal Investigator: Oleg Gligich | |
Holy Cross Hospital | Recruiting |
Fort Lauderdale, Florida, United States, 33308 | |
Contact: Site Public Contact 954-267-7750 | |
Principal Investigator: Tareq Al Baghdadi | |
Mayo Clinic in Florida | Active, not recruiting |
Jacksonville, Florida, United States, 32224-9980 | |
Mount Sinai Medical Center | Recruiting |
Miami Beach, Florida, United States, 33140 | |
Contact: Site Public Contact 305-674-2625 yenrique@msmc.com | |
Principal Investigator: Oleg Gligich | |
Orlando Health Cancer Institute | Recruiting |
Orlando, Florida, United States, 32806 | |
Contact: Site Public Contact 321-841-7246 CancerClinicalTrials@orlandohealth.com | |
Principal Investigator: Daniel Landau | |
United States, Georgia | |
Emory University Hospital Midtown | Recruiting |
Atlanta, Georgia, United States, 30308 | |
Contact: Site Public Contact 888-946-7447 | |
Principal Investigator: Mehmet A. Bilen | |
Emory University Hospital/Winship Cancer Institute | Recruiting |
Atlanta, Georgia, United States, 30322 | |
Contact: Site Public Contact 404-778-1868 | |
Principal Investigator: Mehmet A. Bilen | |
Emory Saint Joseph's Hospital | Recruiting |
Atlanta, Georgia, United States, 30342 | |
Contact: Site Public Contact 404-851-7115 | |
Principal Investigator: Mehmet A. Bilen | |
Emory Johns Creek Hospital | Recruiting |
Johns Creek, Georgia, United States, 30097 | |
Contact: Site Public Contact 404-778-5714 m.lisa.hwang@emory.edu | |
Principal Investigator: Mehmet A. Bilen | |
United States, Idaho | |
Saint Alphonsus Cancer Care Center-Boise | Recruiting |
Boise, Idaho, United States, 83706 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Boise | Recruiting |
Boise, Idaho, United States, 83712 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Cancer Care Center-Caldwell | Recruiting |
Caldwell, Idaho, United States, 83605 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Kootenai Medical Center | Recruiting |
Coeur d'Alene, Idaho, United States, 83814 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Walter Knox Memorial Hospital | Recruiting |
Emmett, Idaho, United States, 83617 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Fruitland | Recruiting |
Fruitland, Idaho, United States, 83619 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Idaho Urologic Institute-Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Medical Center-Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Kootenai Cancer Center | Recruiting |
Post Falls, Idaho, United States, 83854 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Kootenai Cancer Clinic | Recruiting |
Sandpoint, Idaho, United States, 83864 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Twin Falls | Recruiting |
Twin Falls, Idaho, United States, 83301 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
United States, Illinois | |
Rush - Copley Medical Center | Recruiting |
Aurora, Illinois, United States, 60504 | |
Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Illinois CancerCare-Bloomington | Recruiting |
Bloomington, Illinois, United States, 61704 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Loyola Center for Health at Burr Ridge | Recruiting |
Burr Ridge, Illinois, United States, 60527 | |
Contact: Site Public Contact 708-216-9000 | |
Principal Investigator: Stephanie A. Berg | |
Illinois CancerCare-Canton | Recruiting |
Canton, Illinois, United States, 61520 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Memorial Hospital of Carbondale | Recruiting |
Carbondale, Illinois, United States, 62902 | |
Contact: Site Public Contact 618-457-5200 clinical.research@sih.net | |
Principal Investigator: Bryan A. Faller | |
SIH Cancer Institute | Recruiting |
Carterville, Illinois, United States, 62918 | |
Contact: Site Public Contact 618-985-3333 clinical.research@sih.net | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Carthage | Recruiting |
Carthage, Illinois, United States, 62321 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Northwestern University | Recruiting |
Chicago, Illinois, United States, 60611 | |
Contact: Site Public Contact 312-695-1301 cancer@northwestern.edu | |
Principal Investigator: Jeffrey A. Sosman | |
Rush University Medical Center | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-942-5498 clinical_trials@rush.edu | |
Principal Investigator: Alan Tan | |
University of Illinois | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-355-3046 | |
Principal Investigator: Michael Abern | |
University of Chicago Comprehensive Cancer Center | Recruiting |
Chicago, Illinois, United States, 60637 | |
Contact: Site Public Contact 773-702-8222 cancerclinicaltrials@bsd.uchicago.edu | |
Principal Investigator: Walter M. Stadler | |
Carle on Vermilion | Recruiting |
Danville, Illinois, United States, 61832 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Cancer Care Specialists of Illinois - Decatur | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Decatur Memorial Hospital | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Dixon | Recruiting |
Dixon, Illinois, United States, 61021 | |
Contact: Site Public Contact 815-285-7800 | |
Principal Investigator: Bryan A. Faller | |
Carle Physician Group-Effingham | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Crossroads Cancer Center | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Eureka | Recruiting |
Eureka, Illinois, United States, 61530 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Galesburg | Recruiting |
Galesburg, Illinois, United States, 61401 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Western Illinois Cancer Treatment Center | Recruiting |
Galesburg, Illinois, United States, 61401 | |
Contact: Site Public Contact 309-344-2831 | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Kewanee Clinic | Recruiting |
Kewanee, Illinois, United States, 61443 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Northwestern Medicine Lake Forest Hospital | Recruiting |
Lake Forest, Illinois, United States, 60045 | |
Contact: Site Public Contact cancertrials@northwestern.edu | |
Principal Investigator: Jeffrey A. Sosman | |
Illinois CancerCare-Macomb | Recruiting |
Macomb, Illinois, United States, 61455 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Carle Physician Group-Mattoon/Charleston | Recruiting |
Mattoon, Illinois, United States, 61938 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Loyola University Medical Center | Recruiting |
Maywood, Illinois, United States, 60153 | |
Contact: Site Public Contact 708-226-4357 | |
Principal Investigator: Stephanie A. Berg | |
Marjorie Weinberg Cancer Center at Loyola-Gottlieb | Recruiting |
Melrose Park, Illinois, United States, 60160 | |
Contact: Site Public Contact 708-450-4554 | |
Principal Investigator: Stephanie A. Berg | |
Good Samaritan Regional Health Center | Recruiting |
Mount Vernon, Illinois, United States, 62864 | |
Contact: Site Public Contact 618-242-4600 | |
Principal Investigator: Jay W. Carlson | |
UC Comprehensive Cancer Center at Silver Cross | Recruiting |
New Lenox, Illinois, United States, 60451 | |
Contact: Site Public Contact 773-702-8222 cancerclinicaltrials@bsd.uchicago.edu | |
Principal Investigator: Walter M. Stadler | |
Cancer Care Center of O'Fallon | Recruiting |
O'Fallon, Illinois, United States, 62269 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Loyola Center for Cancer Care and Research | Recruiting |
Orland Park, Illinois, United States, 60462 | |
Contact: Site Public Contact 708-216-9000 | |
Principal Investigator: Stephanie A. Berg | |
University of Chicago Medicine-Orland Park | Recruiting |
Orland Park, Illinois, United States, 60462 | |
Contact: Site Public Contact 773-702-8222 cancerclinicaltrials@bsd.uchicago.edu | |
Principal Investigator: Walter M. Stadler | |
Illinois CancerCare-Ottawa Clinic | Recruiting |
Ottawa, Illinois, United States, 61350 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Pekin | Recruiting |
Pekin, Illinois, United States, 61554 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peoria | Recruiting |
Peoria, Illinois, United States, 61615 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Methodist Medical Center of Illinois | Recruiting |
Peoria, Illinois, United States, 61636 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peru | Recruiting |
Peru, Illinois, United States, 61354 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Valley Radiation Oncology | Recruiting |
Peru, Illinois, United States, 61354 | |
Contact: Site Public Contact 815-664-4141 | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Princeton | Recruiting |
Princeton, Illinois, United States, 61356 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Southern Illinois University School of Medicine | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 217-545-7929 | |
Principal Investigator: Bryan A. Faller | |
Springfield Clinic | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 800-444-7541 | |
Principal Investigator: Bryan A. Faller | |
Memorial Medical Center | Recruiting |
Springfield, Illinois, United States, 62781 | |
Contact: Site Public Contact 217-788-3528 | |
Principal Investigator: Bryan A. Faller | |
Southwest Illinois Health Services LLP | Suspended |
Swansea, Illinois, United States, 62226 | |
Carle Cancer Center | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
The Carle Foundation Hospital | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Rush-Copley Healthcare Center | Recruiting |
Yorkville, Illinois, United States, 60560 | |
Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
Principal Investigator: Vamsi K. Vasireddy | |
United States, Indiana | |
Reid Health | Recruiting |
Richmond, Indiana, United States, 47374 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
United States, Iowa | |
Mary Greeley Medical Center | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC - Ames | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-239-4734 ksoder@mcfarlandclinic.com | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC-Boone | Recruiting |
Boone, Iowa, United States, 50036 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Medical Oncology and Hematology Associates-West Des Moines | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Cancer Center-West Lakes | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Mercy Hospital | Recruiting |
Council Bluffs, Iowa, United States, 51503 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Greater Regional Medical Center | Recruiting |
Creston, Iowa, United States, 50801 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Medical Oncology and Hematology Associates-Laurel | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Medical Center - Des Moines | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
McFarland Clinic PC-Trinity Cancer Center | Recruiting |
Fort Dodge, Iowa, United States, 50501 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC-Jefferson | Recruiting |
Jefferson, Iowa, United States, 50129 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC-Marshalltown | Recruiting |
Marshalltown, Iowa, United States, 50158 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Mercy Medical Center-West Lakes | Recruiting |
West Des Moines, Iowa, United States, 50266 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Kansas | |
Cancer Center of Kansas - Chanute | Recruiting |
Chanute, Kansas, United States, 66720 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Dodge City | Recruiting |
Dodge City, Kansas, United States, 67801 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - El Dorado | Recruiting |
El Dorado, Kansas, United States, 67042 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
University of Kansas Clinical Research Center | Recruiting |
Fairway, Kansas, United States, 66205 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
HaysMed University of Kansas Health System | Recruiting |
Hays, Kansas, United States, 67601 | |
Contact: Site Public Contact 785-623-5774 | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
Cancer Center of Kansas-Independence | Recruiting |
Independence, Kansas, United States, 67301 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas-Kingman | Recruiting |
Kingman, Kansas, United States, 67068 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Lawrence Memorial Hospital | Recruiting |
Lawrence, Kansas, United States, 66044 | |
Contact: Site Public Contact 785-505-2800 Stephanie.Norris@LMH.ORG | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
Cancer Center of Kansas-Liberal | Recruiting |
Liberal, Kansas, United States, 67905 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas-Manhattan | Recruiting |
Manhattan, Kansas, United States, 66502 | |
Contact: Site Public Contact 316-268-5784 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - McPherson | Recruiting |
McPherson, Kansas, United States, 67460 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Newton | Recruiting |
Newton, Kansas, United States, 67114 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Olathe Health Cancer Center | Recruiting |
Olathe, Kansas, United States, 66061 | |
Contact: Site Public Contact 913-355-8000 Jeni.wakefield@olathehealth.org | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
Cancer Center of Kansas - Parsons | Recruiting |
Parsons, Kansas, United States, 67357 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Ascension Via Christi - Pittsburg | Recruiting |
Pittsburg, Kansas, United States, 66762 | |
Contact: Site Public Contact 620-235-7900 jennifer.jameson@ascension.org | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
Cancer Center of Kansas - Pratt | Recruiting |
Pratt, Kansas, United States, 67124 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Salina | Recruiting |
Salina, Kansas, United States, 67401 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Salina Regional Health Center | Recruiting |
Salina, Kansas, United States, 67401 | |
Contact: Site Public Contact 785-452-7038 mleepers@srhc.com | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
University of Kansas Health System Saint Francis Campus | Recruiting |
Topeka, Kansas, United States, 66606 | |
Contact: Site Public Contact 785-295-8000 | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
Cancer Center of Kansas - Wellington | Recruiting |
Wellington, Kansas, United States, 67152 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
University of Kansas Hospital-Westwood Cancer Center | Recruiting |
Westwood, Kansas, United States, 66205 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
Cancer Center of Kansas-Wichita Medical Arts Tower | Recruiting |
Wichita, Kansas, United States, 67208 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Ascension Via Christi Hospitals Wichita | Recruiting |
Wichita, Kansas, United States, 67214 | |
Contact: Site Public Contact 800-362-0070 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Wichita | Recruiting |
Wichita, Kansas, United States, 67214 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Winfield | Recruiting |
Winfield, Kansas, United States, 67156 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
United States, Kentucky | |
Flaget Memorial Hospital | Recruiting |
Bardstown, Kentucky, United States, 40004 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Commonwealth Cancer Center-Corbin | Recruiting |
Corbin, Kentucky, United States, 40701 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Joseph Radiation Oncology Resource Center | Recruiting |
Lexington, Kentucky, United States, 40504 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Joseph Hospital East | Recruiting |
Lexington, Kentucky, United States, 40509 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
University of Kentucky/Markey Cancer Center | Recruiting |
Lexington, Kentucky, United States, 40536 | |
Contact: Site Public Contact 859-257-3379 | |
Principal Investigator: Peng Wang | |
Saint Joseph London | Recruiting |
London, Kentucky, United States, 40741 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital | Recruiting |
Louisville, Kentucky, United States, 40202 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saints Mary and Elizabeth Hospital | Recruiting |
Louisville, Kentucky, United States, 40215 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital Medical Center Northeast | Recruiting |
Louisville, Kentucky, United States, 40245 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital Medical Center South | Recruiting |
Shepherdsville, Kentucky, United States, 40165 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Louisiana | |
Hematology/Oncology Clinic PLLC | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-761-3951 Aimee.Alumbaugh@aoncology.com | |
Principal Investigator: Pedro M. Barata | |
Ochsner High Grove | Recruiting |
Baton Rouge, Louisiana, United States, 70836 | |
Contact: Site Public Contact 504-703-8712 Gregory.Johnstone@ochsner.org | |
Principal Investigator: Marc R. Matrana | |
Ochsner Medical Center Kenner | Recruiting |
Kenner, Louisiana, United States, 70065 | |
Contact: Site Public Contact 504-464-8314 cris.molina@ochsner.org | |
Principal Investigator: Marc R. Matrana | |
East Jefferson General Hospital | Recruiting |
Metairie, Louisiana, United States, 70006 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Scott E. Delacroix | |
LSU Healthcare Network / Metairie Multi-Specialty Clinic | Recruiting |
Metairie, Louisiana, United States, 70006 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Scott E. Delacroix | |
Louisiana State University Health Science Center | Recruiting |
New Orleans, Louisiana, United States, 70112 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Scott E. Delacroix | |
Tulane University Health Sciences Center | Recruiting |
New Orleans, Louisiana, United States, 70112 | |
Contact: Site Public Contact 504-988-6121 | |
Principal Investigator: Pedro M. Barata | |
Ochsner Medical Center Jefferson | Recruiting |
New Orleans, Louisiana, United States, 70121 | |
Contact: Site Public Contact 504-703-8712 Gregory.Johnstone@ochsner.org | |
Principal Investigator: Marc R. Matrana | |
United States, Maryland | |
National Institutes of Health Clinical Center | Recruiting |
Bethesda, Maryland, United States, 20892 | |
Contact: Site Public Contact 800-411-1222 | |
Principal Investigator: Andrea B. Apolo | |
United States, Massachusetts | |
Lahey Hospital and Medical Center | Recruiting |
Burlington, Massachusetts, United States, 01805 | |
Contact: Site Public Contact 781-744-3421 cancerclinicaltrials@lahey.org | |
Principal Investigator: Brendan Connell | |
Lahey Medical Center-Peabody | Recruiting |
Peabody, Massachusetts, United States, 01960 | |
Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com | |
Principal Investigator: Brendan Connell | |
Mercy Medical Center | Suspended |
Springfield, Massachusetts, United States, 01104 | |
Winchester Hospital | Recruiting |
Winchester, Massachusetts, United States, 01890 | |
Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com | |
Principal Investigator: Brendan Connell | |
United States, Michigan | |
Saint Joseph Mercy Hospital | Recruiting |
Ann Arbor, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
IHA Hematology Oncology Consultants-Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Joseph Mercy Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Henry Ford Cancer Institute-Downriver | Recruiting |
Brownstown, Michigan, United States, 48183 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
IHA Hematology Oncology Consultants-Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Joseph Mercy Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Caro Cancer Center | Recruiting |
Caro, Michigan, United States, 48723 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
IHA Hematology Oncology Consultants-Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Joseph Mercy Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Hematology Oncology Consultants-Clarkston | Recruiting |
Clarkston, Michigan, United States, 48346 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Newland Medical Associates-Clarkston | Recruiting |
Clarkston, Michigan, United States, 48346 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Henry Ford Macomb Hospital-Clinton Township | Recruiting |
Clinton Township, Michigan, United States, 48038 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
Henry Ford Medical Center-Fairlane | Recruiting |
Dearborn, Michigan, United States, 48126 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
Henry Ford Hospital | Recruiting |
Detroit, Michigan, United States, 48202 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
Ascension Saint John Hospital | Recruiting |
Detroit, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Great Lakes Cancer Management Specialists-Doctors Park | Recruiting |
East China Township, Michigan, United States, 48054 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Genesee Cancer and Blood Disease Treatment Center | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Genesee Hematology Oncology PC | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Genesys Hurley Cancer Institute | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Hurley Medical Center | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Academic Hematology Oncology Specialists | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Michigan Breast Specialists-Grosse Pointe Woods | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Allegiance Health | Recruiting |
Jackson, Michigan, United States, 49201 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
Sparrow Hospital | Recruiting |
Lansing, Michigan, United States, 48912 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Hope Cancer Clinic | Recruiting |
Livonia, Michigan, United States, 48154 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Mary Mercy Hospital | Recruiting |
Livonia, Michigan, United States, 48154 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Great Lakes Cancer Management Specialists-Macomb Medical Campus | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Michigan Breast Specialists-Macomb Township | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Mary's Oncology/Hematology Associates of Marlette | Recruiting |
Marlette, Michigan, United States, 48453 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Henry Ford Medical Center-Columbus | Recruiting |
Novi, Michigan, United States, 48377 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
21st Century Oncology-Pontiac | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Hope Cancer Center | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Newland Medical Associates-Pontiac | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Joseph Mercy Oakland | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Huron Medical Center PC | Suspended |
Port Huron, Michigan, United States, 48060 | |
Lake Huron Medical Center | Suspended |
Port Huron, Michigan, United States, 48060 | |
Great Lakes Cancer Management Specialists-Rochester Hills | Suspended |
Rochester Hills, Michigan, United States, 48309 | |
Ascension Saint Mary's Hospital | Recruiting |
Saginaw, Michigan, United States, 48601 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Oncology Hematology Associates of Saginaw Valley PC | Recruiting |
Saginaw, Michigan, United States, 48604 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Henry Ford Macomb Health Center - Shelby Township | Recruiting |
Shelby, Michigan, United States, 48315 | |
Contact: Site Public Contact 313-916-1784 tpearce1@hfhs.org | |
Principal Investigator: Ding Wang | |
Bhadresh Nayak MD PC-Sterling Heights | Recruiting |
Sterling Heights, Michigan, United States, 48312 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Ascension Saint Joseph Hospital | Recruiting |
Tawas City, Michigan, United States, 48764 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Advanced Breast Care Center PLLC | Recruiting |
Warren, Michigan, United States, 48088 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Great Lakes Cancer Management Specialists-Macomb Professional Building | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Macomb Hematology Oncology PC | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Michigan Breast Specialists-Warren | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint John Macomb-Oakland Hospital | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Henry Ford West Bloomfield Hospital | Recruiting |
West Bloomfield, Michigan, United States, 48322 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
Saint Mary's Oncology/Hematology Associates of West Branch | Recruiting |
West Branch, Michigan, United States, 48661 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Huron Gastroenterology PC | Recruiting |
Ypsilanti, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
IHA Hematology Oncology Consultants-Ann Arbor | Recruiting |
Ypsilanti, Michigan, United States, 48197 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
United States, Minnesota | |
Riverwood Healthcare Center | Recruiting |
Aitkin, Minnesota, United States, 56431 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Saint Joseph's Medical Center | Recruiting |
Brainerd, Minnesota, United States, 56401 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Fairview Ridges Hospital | Recruiting |
Burnsville, Minnesota, United States, 55337 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Minnesota Oncology - Burnsville | Recruiting |
Burnsville, Minnesota, United States, 55337 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Cambridge Medical Center | Recruiting |
Cambridge, Minnesota, United States, 55008 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Mercy Hospital | Recruiting |
Coon Rapids, Minnesota, United States, 55433 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Essentia Health - Deer River Clinic | Recruiting |
Deer River, Minnesota, United States, 56636 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Saint Mary's - Detroit Lakes Clinic | Recruiting |
Detroit Lakes, Minnesota, United States, 56501 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Cancer Center | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Saint Mary's Medical Center | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Miller-Dwan Hospital | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Fairview Southdale Hospital | Recruiting |
Edina, Minnesota, United States, 55435 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Lake Region Healthcare Corporation-Cancer Care | Recruiting |
Fergus Falls, Minnesota, United States, 56537 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health - Fosston | Recruiting |
Fosston, Minnesota, United States, 56542 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Unity Hospital | Recruiting |
Fridley, Minnesota, United States, 55432 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Essentia Health Hibbing Clinic | Recruiting |
Hibbing, Minnesota, United States, 55746 | |
Contact: Site Public Contact 218-786-3308 | |
Principal Investigator: Bret E. Friday | |
Fairview Clinics and Surgery Center Maple Grove | Recruiting |
Maple Grove, Minnesota, United States, 55369 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Minnesota Oncology Hematology PA-Maplewood | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Saint John's Hospital - Healtheast | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Abbott-Northwestern Hospital | Recruiting |
Minneapolis, Minnesota, United States, 55407 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Hennepin County Medical Center | Recruiting |
Minneapolis, Minnesota, United States, 55415 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Health Partners Inc | Recruiting |
Minneapolis, Minnesota, United States, 55454 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Monticello Cancer Center | Recruiting |
Monticello, Minnesota, United States, 55362 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
New Ulm Medical Center | Recruiting |
New Ulm, Minnesota, United States, 56073 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Essentia Health - Park Rapids | Recruiting |
Park Rapids, Minnesota, United States, 56470 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Fairview Northland Medical Center | Recruiting |
Princeton, Minnesota, United States, 55371 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
North Memorial Medical Health Center | Recruiting |
Robbinsdale, Minnesota, United States, 55422 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Mayo Clinic in Rochester | Recruiting |
Rochester, Minnesota, United States, 55905 | |
Contact: Site Public Contact 855-776-0015 | |
Principal Investigator: Lance C. Pagliaro | |
Park Nicollet Clinic - Saint Louis Park | Recruiting |
Saint Louis Park, Minnesota, United States, 55416 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Regions Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55101 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
United Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55102 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Essentia Health Sandstone | Recruiting |
Sandstone, Minnesota, United States, 55072 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Saint Francis Regional Medical Center | Recruiting |
Shakopee, Minnesota, United States, 55379 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Lakeview Hospital | Recruiting |
Stillwater, Minnesota, United States, 55082 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Essentia Health Virginia Clinic | Recruiting |
Virginia, Minnesota, United States, 55792 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Ridgeview Medical Center | Recruiting |
Waconia, Minnesota, United States, 55387 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Rice Memorial Hospital | Recruiting |
Willmar, Minnesota, United States, 56201 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Minnesota Oncology Hematology PA-Woodbury | Recruiting |
Woodbury, Minnesota, United States, 55125 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Fairview Lakes Medical Center | Recruiting |
Wyoming, Minnesota, United States, 55092 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
United States, Mississippi | |
University of Mississippi Medical Center | Recruiting |
Jackson, Mississippi, United States, 39216 | |
Contact: Site Public Contact 601-815-6700 | |
Principal Investigator: John C. Henegan | |
United States, Missouri | |
Saint Louis Cancer and Breast Institute-Ballwin | Recruiting |
Ballwin, Missouri, United States, 63011 | |
Contact: Site Public Contact 314-251-7058 | |
Principal Investigator: Jay W. Carlson | |
Parkland Health Center-Bonne Terre | Suspended |
Bonne Terre, Missouri, United States, 63628 | |
Cox Cancer Center Branson | Suspended |
Branson, Missouri, United States, 65616 | |
Saint Francis Medical Center | Recruiting |
Cape Girardeau, Missouri, United States, 63703 | |
Contact: Site Public Contact 573-334-2230 sfmc@sfmc.net | |
Principal Investigator: Bryan A. Faller | |
Southeast Cancer Center | Recruiting |
Cape Girardeau, Missouri, United States, 63703 | |
Contact: Site Public Contact 573-651-5550 | |
Principal Investigator: Bryan A. Faller | |
Siteman Cancer Center at West County Hospital | Recruiting |
Creve Coeur, Missouri, United States, 63141 | |
Contact: Site Public Contact 800-600-3606 info@siteman.wustl.edu | |
Principal Investigator: Joel Picus | |
Parkland Health Center - Farmington | Recruiting |
Farmington, Missouri, United States, 63640 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Capital Region Southwest Campus | Recruiting |
Jefferson City, Missouri, United States, 65109 | |
Contact: Site Public Contact 573-632-4814 swooden@mail.crmc.org | |
Principal Investigator: Bryan A. Faller | |
Freeman Health System | Recruiting |
Joplin, Missouri, United States, 64804 | |
Contact: Site Public Contact 417-347-4030 LJCrockett@freemanhealth.com | |
Principal Investigator: Jay W. Carlson | |
Mercy Hospital Joplin | Recruiting |
Joplin, Missouri, United States, 64804 | |
Contact: Site Public Contact 417-556-3074 esmeralda.carrillo@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Truman Medical Centers | Recruiting |
Kansas City, Missouri, United States, 64108 | |
Contact: Site Public Contact 816-404-4375 | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
University of Kansas Cancer Center - Lee's Summit | Recruiting |
Lee's Summit, Missouri, United States, 64064 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Elizabeth M. Wulff-Burchfield | |
Delbert Day Cancer Institute at PCRMC | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-8776 kaysmith@phelpshealth.org | |
Principal Investigator: Jay W. Carlson | |
Mercy Clinic-Rolla-Cancer and Hematology | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-6379 | |
Principal Investigator: Jay W. Carlson | |
Heartland Regional Medical Center | Recruiting |
Saint Joseph, Missouri, United States, 64506 | |
Contact: Site Public Contact 816-271-7937 linda.schumacher@mymlc.com | |
Principal Investigator: Jay W. Carlson | |
Saint Louis Cancer and Breast Institute-South City | Recruiting |
Saint Louis, Missouri, United States, 63109 | |
Contact: Site Public Contact 314-353-1870 | |
Principal Investigator: Jay W. Carlson | |
Washington University School of Medicine | Recruiting |
Saint Louis, Missouri, United States, 63110 | |
Contact: Site Public Contact 800-600-3606 info@siteman.wustl.edu | |
Principal Investigator: Joel Picus | |
Mercy Hospital South | Recruiting |
Saint Louis, Missouri, United States, 63128 | |
Contact: Site Public Contact janet.lesko@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Siteman Cancer Center-South County | Recruiting |
Saint Louis, Missouri, United States, 63129 | |
Contact: Site Public Contact 800-600-3606 info@siteman.wustl.edu | |
Principal Investigator: Joel Picus | |
Missouri Baptist Medical Center | Recruiting |
Saint Louis, Missouri, United States, 63131 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Siteman Cancer Center at Christian Hospital | Recruiting |
Saint Louis, Missouri, United States, 63136 | |
Contact: Site Public Contact 800-600-3606 info@siteman.wustl.edu | |
Principal Investigator: Joel Picus | |
Mercy Hospital Saint Louis | Recruiting |
Saint Louis, Missouri, United States, 63141 | |
Contact: Site Public Contact 314-251-7066 | |
Principal Investigator: Jay W. Carlson | |
Siteman Cancer Center at Saint Peters Hospital | Recruiting |
Saint Peters, Missouri, United States, 63376 | |
Contact: Site Public Contact 800-600-3606 info@siteman.wustl.edu | |
Principal Investigator: Joel Picus | |
Sainte Genevieve County Memorial Hospital | Recruiting |
Sainte Genevieve, Missouri, United States, 63670 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Springfield | Recruiting |
Springfield, Missouri, United States, 65804 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
CoxHealth South Hospital | Recruiting |
Springfield, Missouri, United States, 65807 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
Missouri Baptist Sullivan Hospital | Recruiting |
Sullivan, Missouri, United States, 63080 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Missouri Baptist Outpatient Center-Sunset Hills | Recruiting |
Sunset Hills, Missouri, United States, 63127 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Washington | Recruiting |
Washington, Missouri, United States, 63090 | |
Contact: Site Public Contact 636-390-1600 | |
Principal Investigator: Jay W. Carlson | |
United States, Montana | |
Community Hospital of Anaconda | Recruiting |
Anaconda, Montana, United States, 59711 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Billings Clinic Cancer Center | Recruiting |
Billings, Montana, United States, 59101 | |
Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
Principal Investigator: John M. Schallenkamp | |
Bozeman Deaconess Hospital | Recruiting |
Bozeman, Montana, United States, 59715 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Benefis Healthcare- Sletten Cancer Institute | Recruiting |
Great Falls, Montana, United States, 59405 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Great Falls Clinic | Recruiting |
Great Falls, Montana, United States, 59405 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Peter's Community Hospital | Suspended |
Helena, Montana, United States, 59601 | |
Kalispell Regional Medical Center | Recruiting |
Kalispell, Montana, United States, 59901 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Patrick Hospital - Community Hospital | Recruiting |
Missoula, Montana, United States, 59802 | |
Contact: Site Public Contact 406-327-3118 amy.hanneman@providence.org | |
Principal Investigator: Alison K. Conlin | |
Community Medical Hospital | Recruiting |
Missoula, Montana, United States, 59804 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
United States, Nebraska | |
Nebraska Medicine-Bellevue | Recruiting |
Bellevue, Nebraska, United States, 68123 | |
Contact: Site Public Contact 402-559-6941 unmcrsa@unmc.edu | |
Principal Investigator: Benjamin A. Teply | |
CHI Health Saint Francis | Recruiting |
Grand Island, Nebraska, United States, 68803 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
CHI Health Good Samaritan | Recruiting |
Kearney, Nebraska, United States, 68847 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Elizabeth Regional Medical Center | Recruiting |
Lincoln, Nebraska, United States, 68510 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Nebraska Methodist Hospital | Recruiting |
Omaha, Nebraska, United States, 68114 | |
Contact: Site Public Contact 402-354-5144 | |
Principal Investigator: Ralph J. Hauke | |
Nebraska Medicine-Village Pointe | Recruiting |
Omaha, Nebraska, United States, 68118 | |
Contact: Site Public Contact 402-559-5600 | |
Principal Investigator: Benjamin A. Teply | |
Alegent Health Immanuel Medical Center | Recruiting |
Omaha, Nebraska, United States, 68122 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Bergan Mercy Medical Center | Recruiting |
Omaha, Nebraska, United States, 68124 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Lakeside Hospital | Recruiting |
Omaha, Nebraska, United States, 68130 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Creighton University Medical Center | Recruiting |
Omaha, Nebraska, United States, 68131 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
University of Nebraska Medical Center | Recruiting |
Omaha, Nebraska, United States, 68198 | |
Contact: Site Public Contact 402-559-6941 unmcrsa@unmc.edu | |
Principal Investigator: Benjamin A. Teply | |
Midlands Community Hospital | Recruiting |
Papillion, Nebraska, United States, 68046 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Nevada | |
Carson Tahoe Regional Medical Center | Recruiting |
Carson City, Nevada, United States, 89703 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Cancer and Blood Specialists-Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Horizon Ridge | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Cancer Center-Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Seven Hills | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
21st Century Oncology-Henderson | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Southeast Henderson | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Green Valley | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Pebble | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Green Valley | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Pecos | Recruiting |
Las Vegas, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Desert West Surgery | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Charleston | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
University Medical Center of Southern Nevada | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Hope Cancer Care of Nevada | Recruiting |
Las Vegas, Nevada, United States, 89103 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Cancer and Blood Specialists-Shadow | Suspended |
Las Vegas, Nevada, United States, 89106 | |
Radiation Oncology Centers of Nevada Central | Recruiting |
Las Vegas, Nevada, United States, 89106 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Central | Recruiting |
Las Vegas, Nevada, United States, 89106 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
21st Century Oncology | Recruiting |
Las Vegas, Nevada, United States, 89109 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway | Suspended |
Las Vegas, Nevada, United States, 89109 | |
Sunrise Hospital and Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89109 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
HealthCare Partners Medical Group Oncology/Hematology-San Martin | Suspended |
Las Vegas, Nevada, United States, 89113 | |
Las Vegas Prostate Cancer Center | Recruiting |
Las Vegas, Nevada, United States, 89113 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Sunset | Recruiting |
Las Vegas, Nevada, United States, 89113 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Radiation Oncology Centers of Nevada Southeast | Recruiting |
Las Vegas, Nevada, United States, 89119 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
21st Century Oncology-Vegas Tenaya | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Ann M Wierman MD LTD | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Cancer and Blood Specialists-Tenaya | Suspended |
Las Vegas, Nevada, United States, 89128 | |
Comprehensive Cancer Centers of Nevada - Northwest | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
HealthCare Partners Medical Group Oncology/Hematology-Tenaya | Suspended |
Las Vegas, Nevada, United States, 89128 | |
Las Vegas Urology - Cathedral Rock | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Smoke Ranch | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact research@smcrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at MountainView | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Northwest | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Alliance for Childhood Diseases/Cure 4 the Kids Foundation | Recruiting |
Las Vegas, Nevada, United States, 89135 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Town Center | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Summerlin | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Summerlin Hospital Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Cancer Center-Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89148-2405 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
21st Century Oncology-Fort Apache | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Fort Apache | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Southwest | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills | Suspended |
Las Vegas, Nevada, United States, 89149 | |
Comprehensive Cancer Centers of Nevada - Central Valley | Recruiting |
Las Vegas, Nevada, United States, 89169 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
University Cancer Center | Recruiting |
Las Vegas, Nevada, United States, 89169 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Hope Cancer Care of Nevada-Pahrump | Recruiting |
Pahrump, Nevada, United States, 89048 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Renown Regional Medical Center | Recruiting |
Reno, Nevada, United States, 89502 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Saint Mary's Regional Medical Center | Recruiting |
Reno, Nevada, United States, 89503 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Radiation Oncology Associates | Recruiting |
Reno, Nevada, United States, 89509 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
United States, New Jersey | |
Memorial Sloan Kettering Bergen | Recruiting |
Montvale, New Jersey, United States, 07645 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Samuel A. Funt | |
United States, New York | |
New York-Presbyterian/Brooklyn Methodist Hospital | Recruiting |
Brooklyn, New York, United States, 11215 | |
Contact: Site Public Contact 718-780-3677 Adg9003@nyp.org | |
Principal Investigator: Panagiotis J. Vlachostergios | |
Maimonides Medical Center | Recruiting |
Brooklyn, New York, United States, 11219 | |
Contact: Site Public Contact 718-765-2500 | |
Principal Investigator: Kevin Becker | |
Roswell Park Cancer Institute | Recruiting |
Buffalo, New York, United States, 14263 | |
Contact: Site Public Contact 800-767-9355 askroswell@roswellpark.org | |
Principal Investigator: Ellis G. Levine | |
Northwell Health/Center for Advanced Medicine | Recruiting |
Lake Success, New York, United States, 11042 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Thomas P. Bradley | |
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center | Recruiting |
New York, New York, United States, 10032 | |
Contact: Site Public Contact 212-305-6361 nr2616@cumc.columbia.edu | |
Principal Investigator: Emerson A. Lim | |
Memorial Sloan Kettering Cancer Center | Recruiting |
New York, New York, United States, 10065 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Samuel A. Funt | |
NYP/Weill Cornell Medical Center | Recruiting |
New York, New York, United States, 10065 | |
Contact: Site Public Contact 212-746-1848 | |
Principal Investigator: Cora N. Sternberg | |
University of Rochester | Recruiting |
Rochester, New York, United States, 14642 | |
Contact: Site Public Contact 585-275-5830 | |
Principal Investigator: Paul M. Barr | |
State University of New York Upstate Medical University | Recruiting |
Syracuse, New York, United States, 13210 | |
Contact: Site Public Contact 315-464-5476 | |
Principal Investigator: Alina Basnet | |
United States, North Carolina | |
UNC Lineberger Comprehensive Cancer Center | Recruiting |
Chapel Hill, North Carolina, United States, 27599 | |
Contact: Site Public Contact 877-668-0683 cancerclinicaltrials@med.unc.edu | |
Principal Investigator: Tracy L. Rose | |
Margaret R Pardee Memorial Hospital | Recruiting |
Hendersonville, North Carolina, United States, 28791 | |
Contact: Site Public Contact 828-696-4716 karen.morris@unchealth.unc.edu | |
Principal Investigator: James E. Radford | |
United States, North Dakota | |
Essentia Health Cancer Center-South University Clinic | Recruiting |
Fargo, North Dakota, United States, 58103 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health - Jamestown Clinic | Recruiting |
Jamestown, North Dakota, United States, 58401 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
United States, Ohio | |
Indu and Raj Soin Medical Center | Recruiting |
Beavercreek, Ohio, United States, 45431 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Strecker Cancer Center-Belpre | Recruiting |
Belpre, Ohio, United States, 45714 | |
Contact: Site Public Contact 800-523-3977 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Saint Elizabeth Boardman Hospital | Recruiting |
Boardman, Ohio, United States, 44512 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Dayton Physicians LLC-Miami Valley South | Recruiting |
Centerville, Ohio, United States, 45459 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Miami Valley Hospital South | Recruiting |
Centerville, Ohio, United States, 45459 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Adena Regional Medical Center | Recruiting |
Chillicothe, Ohio, United States, 45601 | |
Contact: Site Public Contact 877-779-7585 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
University of Cincinnati/Barrett Cancer Center | Recruiting |
Cincinnati, Ohio, United States, 45219 | |
Contact: Site Public Contact 513-558-4553 uchealthnews@uc.edu | |
Principal Investigator: Shuchi Gulati | |
Good Samaritan Hospital - Cincinnati | Recruiting |
Cincinnati, Ohio, United States, 45220 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Oncology Hematology Care Inc-Kenwood | Recruiting |
Cincinnati, Ohio, United States, 45236 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Bethesda North Hospital | Recruiting |
Cincinnati, Ohio, United States, 45242 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
TriHealth Cancer Institute-Westside | Recruiting |
Cincinnati, Ohio, United States, 45247 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
TriHealth Cancer Institute-Anderson | Recruiting |
Cincinnati, Ohio, United States, 45255 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Ohio State University Comprehensive Cancer Center | Recruiting |
Columbus, Ohio, United States, 43210 | |
Contact: Site Public Contact 800-293-5066 Jamesline@osumc.edu | |
Principal Investigator: Amir Mortazavi | |
Mount Carmel East Hospital | Recruiting |
Columbus, Ohio, United States, 43213 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Columbus Oncology and Hematology Associates Inc | Recruiting |
Columbus, Ohio, United States, 43214 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Riverside Methodist Hospital | Recruiting |
Columbus, Ohio, United States, 43214 | |
Contact: Site Public Contact 614-566-4475 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Grant Medical Center | Recruiting |
Columbus, Ohio, United States, 43215 | |
Contact: Site Public Contact 614-566-4475 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
The Mark H Zangmeister Center | Recruiting |
Columbus, Ohio, United States, 43219 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Mount Carmel Health Center West | Recruiting |
Columbus, Ohio, United States, 43222 | |
Contact: Site Public Contact 614-234-5433 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Doctors Hospital | Recruiting |
Columbus, Ohio, United States, 43228 | |
Contact: Site Public Contact 614-566-3275 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Good Samaritan Hospital - Dayton | Suspended |
Dayton, Ohio, United States, 45406 | |
Miami Valley Hospital | Recruiting |
Dayton, Ohio, United States, 45409 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Dayton Physician LLC-Miami Valley Hospital North | Recruiting |
Dayton, Ohio, United States, 45415 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Miami Valley Hospital North | Recruiting |
Dayton, Ohio, United States, 45415 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Delaware Health Center-Grady Cancer Center | Recruiting |
Delaware, Ohio, United States, 43015 | |
Contact: Site Public Contact 740-615-0227 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Grady Memorial Hospital | Recruiting |
Delaware, Ohio, United States, 43015 | |
Contact: Site Public Contact 740-615-2403 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Dublin Methodist Hospital | Recruiting |
Dublin, Ohio, United States, 43016 | |
Contact: Site Public Contact 800-752-9119 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Armes Family Cancer Center | Recruiting |
Findlay, Ohio, United States, 45840 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Blanchard Valley Hospital | Recruiting |
Findlay, Ohio, United States, 45840 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Orion Cancer Care | Recruiting |
Findlay, Ohio, United States, 45840 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Atrium Medical Center-Middletown Regional Hospital | Recruiting |
Franklin, Ohio, United States, 45005-1066 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Dayton Physicians LLC-Atrium | Recruiting |
Franklin, Ohio, United States, 45005 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Central Ohio Breast and Endocrine Surgery | Recruiting |
Gahanna, Ohio, United States, 43230 | |
Contact: Site Public Contact 614-488-2745 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Dayton Physicians LLC-Wayne | Recruiting |
Greenville, Ohio, United States, 45331 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Wayne Hospital | Recruiting |
Greenville, Ohio, United States, 45331 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Mount Carmel Grove City Hospital | Recruiting |
Grove City, Ohio, United States, 43123 | |
Contact: Site Public Contact 877-779-7585 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Greater Dayton Cancer Center | Recruiting |
Kettering, Ohio, United States, 45409 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
First Dayton Cancer Care | Suspended |
Kettering, Ohio, United States, 45420 | |
Kettering Medical Center | Recruiting |
Kettering, Ohio, United States, 45429 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Fairfield Medical Center | Recruiting |
Lancaster, Ohio, United States, 43130 | |
Contact: Site Public Contact 740-687-8863 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
OhioHealth Mansfield Hospital | Recruiting |
Mansfield, Ohio, United States, 44903 | |
Contact: Site Public Contact 419-526-8018 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Marietta Memorial Hospital | Recruiting |
Marietta, Ohio, United States, 45750 | |
Contact: Site Public Contact 800-523-3977 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
OhioHealth Marion General Hospital | Recruiting |
Marion, Ohio, United States, 43302 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Knox Community Hospital | Recruiting |
Mount Vernon, Ohio, United States, 43050 | |
Contact: Site Public Contact 740-393-9000 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Licking Memorial Hospital | Recruiting |
Newark, Ohio, United States, 43055 | |
Contact: Site Public Contact 740-348-4000 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Newark Radiation Oncology | Recruiting |
Newark, Ohio, United States, 43055 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Southern Ohio Medical Center | Recruiting |
Portsmouth, Ohio, United States, 45662 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Springfield Regional Cancer Center | Recruiting |
Springfield, Ohio, United States, 45504 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Springfield Regional Medical Center | Recruiting |
Springfield, Ohio, United States, 45505 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Dayton Physicians LLC-Upper Valley | Recruiting |
Troy, Ohio, United States, 45373 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Upper Valley Medical Center | Recruiting |
Troy, Ohio, United States, 45373 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Saint Joseph Warren Hospital | Recruiting |
Warren, Ohio, United States, 44484 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
University Pointe | Recruiting |
West Chester, Ohio, United States, 45069 | |
Contact: Site Public Contact clinicaltrials@ucphysicians.com | |
Principal Investigator: Shuchi Gulati | |
Saint Ann's Hospital | Recruiting |
Westerville, Ohio, United States, 43081 | |
Contact: Site Public Contact 614-234-5433 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Saint Elizabeth Youngstown Hospital | Recruiting |
Youngstown, Ohio, United States, 44501 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Genesis Healthcare System Cancer Care Center | Recruiting |
Zanesville, Ohio, United States, 43701 | |
Contact: Site Public Contact 740-454-5232 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
United States, Oklahoma | |
Cancer Centers of Southwest Oklahoma Research | Recruiting |
Lawton, Oklahoma, United States, 73505 | |
Contact: Site Public Contact 877-231-4440 | |
Principal Investigator: Abhishek Tripathi | |
University of Oklahoma Health Sciences Center | Recruiting |
Oklahoma City, Oklahoma, United States, 73104 | |
Contact: Site Public Contact 405-271-8777 ou-clinical-trials@ouhsc.edu | |
Principal Investigator: Abhishek Tripathi | |
Mercy Hospital Oklahoma City | Recruiting |
Oklahoma City, Oklahoma, United States, 73120 | |
Contact: Site Public Contact 405-752-3402 | |
Principal Investigator: Jay W. Carlson | |
Oklahoma Cancer Specialists and Research Institute-Tulsa | Recruiting |
Tulsa, Oklahoma, United States, 74146 | |
Contact: Site Public Contact 918-505-3200 | |
Principal Investigator: Abhishek Tripathi | |
United States, Oregon | |
Saint Alphonsus Medical Center-Baker City | Recruiting |
Baker City, Oregon, United States, 97814 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Charles Health System | Recruiting |
Bend, Oregon, United States, 97701 | |
Contact: Site Public Contact 541-706-2909 nosall@stcharleshealthcare.org | |
Principal Investigator: Alison K. Conlin | |
Clackamas Radiation Oncology Center | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Cancer Institute Clackamas Clinic | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Bay Area Hospital | Recruiting |
Coos Bay, Oregon, United States, 97420 | |
Contact: Site Public Contact 541-269-8392 cherie.cox@bayareahospital.org | |
Principal Investigator: Alison K. Conlin | |
Providence Newberg Medical Center | Recruiting |
Newberg, Oregon, United States, 97132 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Medical Center-Ontario | Recruiting |
Ontario, Oregon, United States, 97914 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Providence Portland Medical Center | Recruiting |
Portland, Oregon, United States, 97213 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Saint Vincent Medical Center | Recruiting |
Portland, Oregon, United States, 97225 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Oregon Health and Science University | Recruiting |
Portland, Oregon, United States, 97239 | |
Contact: Site Public Contact 503-494-1080 trials@ohsu.edu | |
Principal Investigator: Christopher W. Ryan | |
Saint Charles Health System-Redmond | Recruiting |
Redmond, Oregon, United States, 97756 | |
Contact: Site Public Contact 541-706-2909 | |
Principal Investigator: Alison K. Conlin | |
United States, Pennsylvania | |
Lehigh Valley Hospital-Cedar Crest | Recruiting |
Allentown, Pennsylvania, United States, 18103 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Lehigh Valley Hospital - Muhlenberg | Recruiting |
Bethlehem, Pennsylvania, United States, 18017 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Pocono Medical Center | Recruiting |
East Stroudsburg, Pennsylvania, United States, 18301 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Vincent Hospital | Recruiting |
Erie, Pennsylvania, United States, 16544 | |
Contact: Site Public Contact 814-452-5000 | |
Principal Investigator: Shifeng S. Mao | |
UPMC Cancer Centers - Arnold Palmer Pavilion | Recruiting |
Greensburg, Pennsylvania, United States, 15601 | |
Contact: Site Public Contact 724-838-1900 | |
Principal Investigator: Leonard J. Appleman | |
Lehigh Valley Hospital-Hazleton | Recruiting |
Hazleton, Pennsylvania, United States, 18201 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Jefferson Hospital | Recruiting |
Jefferson Hills, Pennsylvania, United States, 15025 | |
Contact: Site Public Contact 412-359-3043 ddefazio@wpahs.org | |
Principal Investigator: Shifeng S. Mao | |
Forbes Hospital | Recruiting |
Monroeville, Pennsylvania, United States, 15146 | |
Contact: Site Public Contact 412-858-7746 | |
Principal Investigator: Shifeng S. Mao | |
UPMC Cancer Center - Monroeville | Recruiting |
Monroeville, Pennsylvania, United States, 15146 | |
Contact: Site Public Contact 773-702-9171 protocols@AllianceNCTN.org | |
Principal Investigator: Leonard J. Appleman | |
Allegheny Valley Hospital | Recruiting |
Natrona Heights, Pennsylvania, United States, 15065 | |
Contact: Site Public Contact 724-226-7380 | |
Principal Investigator: Shifeng S. Mao | |
Allegheny General Hospital | Recruiting |
Pittsburgh, Pennsylvania, United States, 15212 | |
Contact: Site Public Contact 877-284-2000 | |
Principal Investigator: Shifeng S. Mao | |
West Penn Hospital | Recruiting |
Pittsburgh, Pennsylvania, United States, 15224 | |
Contact: Site Public Contact 412-578-5000 | |
Principal Investigator: Shifeng S. Mao | |
University of Pittsburgh Cancer Institute (UPCI) | Recruiting |
Pittsburgh, Pennsylvania, United States, 15232 | |
Contact: Site Public Contact 412-647-8073 | |
Principal Investigator: Leonard J. Appleman | |
UPMC-Shadyside Hospital | Recruiting |
Pittsburgh, Pennsylvania, United States, 15232 | |
Contact: Site Public Contact 412-621-2334 | |
Principal Investigator: Leonard J. Appleman | |
UPMC-Passavant Hospital | Recruiting |
Pittsburgh, Pennsylvania, United States, 15237 | |
Contact: Site Public Contact 412-367-6454 | |
Principal Investigator: Leonard J. Appleman | |
Wexford Health and Wellness Pavilion | Recruiting |
Wexford, Pennsylvania, United States, 15090 | |
Contact: Site Public Contact 412-359-3043 ddefazio@wpahs.org | |
Principal Investigator: Shifeng S. Mao | |
United States, South Carolina | |
Medical University of South Carolina | Recruiting |
Charleston, South Carolina, United States, 29425 | |
Contact: Site Public Contact 843-792-9321 hcc-clinical-trials@musc.edu | |
Principal Investigator: Theodore S. Gourdin | |
United States, Tennessee | |
Vanderbilt-Ingram Cancer Center Cool Springs | Recruiting |
Franklin, Tennessee, United States, 37067 | |
Contact: Site Public Contact 800-811-8480 | |
Principal Investigator: Nancy B. Davis | |
Vanderbilt Breast Center at One Hundred Oaks | Recruiting |
Nashville, Tennessee, United States, 37204 | |
Contact: Site Public Contact 800-811-8480 | |
Principal Investigator: Nancy B. Davis | |
Vanderbilt University/Ingram Cancer Center | Recruiting |
Nashville, Tennessee, United States, 37232 | |
Contact: Site Public Contact 800-811-8480 | |
Principal Investigator: Nancy B. Davis | |
United States, Texas | |
Saint Joseph Regional Cancer Center | Recruiting |
Bryan, Texas, United States, 77802 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
UT Southwestern/Simmons Cancer Center-Dallas | Recruiting |
Dallas, Texas, United States, 75390 | |
Contact: Site Public Contact 214-648-7097 canceranswerline@UTSouthwestern.edu | |
Principal Investigator: Suzanne M. Cole | |
UT Southwestern/Simmons Cancer Center-Fort Worth | Recruiting |
Fort Worth, Texas, United States, 76104 | |
Contact: Site Public Contact 214-648-7097 canceranswerline@UTSouthwestern.edu | |
Principal Investigator: Suzanne M. Cole | |
UT Southwestern Clinical Center at Richardson/Plano | Recruiting |
Richardson, Texas, United States, 75080 | |
Contact: Site Public Contact 972-669-7044 Suzanne.cole@utsouthwestern.edu | |
Principal Investigator: Suzanne M. Cole | |
United States, Washington | |
Providence Regional Cancer System-Aberdeen | Recruiting |
Aberdeen, Washington, United States, 98520 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Overlake Medical Center | Recruiting |
Bellevue, Washington, United States, 98004 | |
Contact: Site Public Contact 425-688-5407 OHMCResearch@overlakehospital.org | |
Principal Investigator: John A. Ellerton | |
PeaceHealth Saint Joseph Medical Center | Recruiting |
Bellingham, Washington, United States, 98225 | |
Contact: Site Public Contact 360-788-8238 lkey@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Harrison HealthPartners Hematology and Oncology-Bremerton | Recruiting |
Bremerton, Washington, United States, 98310 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Harrison Medical Center | Recruiting |
Bremerton, Washington, United States, 98310 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Highline Medical Center-Main Campus | Recruiting |
Burien, Washington, United States, 98166 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Providence Regional Cancer System-Centralia | Recruiting |
Centralia, Washington, United States, 98531 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Cancer Institute-Edmonds | Recruiting |
Edmonds, Washington, United States, 98026 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Saint Elizabeth Hospital | Recruiting |
Enumclaw, Washington, United States, 98022 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Providence Regional Cancer Partnership | Recruiting |
Everett, Washington, United States, 98201 | |
Contact: Site Public Contact 425-261-3529 marilyn.birchman@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Francis Hospital | Recruiting |
Federal Way, Washington, United States, 98003 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Swedish Cancer Institute-Issaquah | Recruiting |
Issaquah, Washington, United States, 98029 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Kadlec Clinic Hematology and Oncology | Recruiting |
Kennewick, Washington, United States, 99336 | |
Contact: Site Public Contact 509-783-4637 research@kadlecmed.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Lacey | Recruiting |
Lacey, Washington, United States, 98503 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Clare Hospital | Recruiting |
Lakewood, Washington, United States, 98499 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
PeaceHealth Saint John Medical Center | Recruiting |
Longview, Washington, United States, 98632 | |
Contact: Site Public Contact 360-514-2016 kmakin-bond@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Harrison HealthPartners Hematology and Oncology-Poulsbo | Recruiting |
Poulsbo, Washington, United States, 98370 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Valley Medical Center | Recruiting |
Renton, Washington, United States, 98055 | |
Contact: Site Public Contact 425-228-3440 research@valleymed.org | |
Principal Investigator: John A. Ellerton | |
Pacific Gynecology Specialists | Recruiting |
Seattle, Washington, United States, 98104 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Medical Center-Ballard Campus | Recruiting |
Seattle, Washington, United States, 98107 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Medical Center-First Hill | Recruiting |
Seattle, Washington, United States, 98122-4307 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Medical Center-Cherry Hill | Recruiting |
Seattle, Washington, United States, 98122-5711 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
PeaceHealth United General Medical Center | Recruiting |
Sedro-Woolley, Washington, United States, 98284 | |
Contact: Site Public Contact 360-788-8238 lkey@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Shelton | Recruiting |
Shelton, Washington, United States, 98584 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Franciscan Research Center-Northwest Medical Plaza | Recruiting |
Tacoma, Washington, United States, 98405 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Northwest Medical Specialties PLLC | Recruiting |
Tacoma, Washington, United States, 98405 | |
Contact: Site Public Contact 253-306-0532 research@southsoundcare.org | |
Principal Investigator: Richard L. Deming | |
PeaceHealth Southwest Medical Center | Recruiting |
Vancouver, Washington, United States, 98664 | |
Contact: Site Public Contact 360-514-3940 kmakin-bond@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Providence Saint Mary Regional Cancer Center | Recruiting |
Walla Walla, Washington, United States, 99362 | |
Contact: Site Public Contact 509-897-5993 Cheryl.Dodd@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Yelm | Recruiting |
Yelm, Washington, United States, 98597 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
United States, Wisconsin | |
Duluth Clinic Ashland | Recruiting |
Ashland, Wisconsin, United States, 54806 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Northwest Wisconsin Cancer Center | Recruiting |
Ashland, Wisconsin, United States, 54806 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Aurora Cancer Care-Southern Lakes VLCC | Recruiting |
Burlington, Wisconsin, United States, 53105 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora Saint Luke's South Shore | Recruiting |
Cudahy, Wisconsin, United States, 53110 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Marshfield Medical Center-EC Cancer Center | Recruiting |
Eau Claire, Wisconsin, United States, 54701 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Michael Husak | |
Mayo Clinic Health System-Eau Claire Clinic | Recruiting |
Eau Claire, Wisconsin, United States, 54701 | |
Contact: Site Public Contact 855-776-0015 | |
Principal Investigator: Lance C. Pagliaro | |
Aurora Health Care Germantown Health Center | Recruiting |
Germantown, Wisconsin, United States, 53022 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora Cancer Care-Grafton | Recruiting |
Grafton, Wisconsin, United States, 53024 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora BayCare Medical Center | Recruiting |
Green Bay, Wisconsin, United States, 54311 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora Cancer Care-Kenosha South | Recruiting |
Kenosha, Wisconsin, United States, 53142 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora Bay Area Medical Group-Marinette | Recruiting |
Marinette, Wisconsin, United States, 54143 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Marshfield Medical Center-Marshfield | Recruiting |
Marshfield, Wisconsin, United States, 54449 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Michael Husak | |
Aurora Cancer Care-Milwaukee | Recruiting |
Milwaukee, Wisconsin, United States, 53209 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora Saint Luke's Medical Center | Recruiting |
Milwaukee, Wisconsin, United States, 53215 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora Sinai Medical Center | Recruiting |
Milwaukee, Wisconsin, United States, 53233 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Marshfield Clinic-Minocqua Center | Recruiting |
Minocqua, Wisconsin, United States, 54548 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Michael Husak | |
ProHealth D N Greenwald Center | Recruiting |
Mukwonago, Wisconsin, United States, 53149 | |
Contact: Site Public Contact research.institute@phci.org | |
Principal Investigator: Timothy R. Wassenaar | |
Cancer Center of Western Wisconsin | Recruiting |
New Richmond, Wisconsin, United States, 54017 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
ProHealth Oconomowoc Memorial Hospital | Recruiting |
Oconomowoc, Wisconsin, United States, 53066 | |
Contact: Site Public Contact 262-928-7878 | |
Principal Investigator: Timothy R. Wassenaar | |
Vince Lombardi Cancer Clinic - Oshkosh | Recruiting |
Oshkosh, Wisconsin, United States, 54904 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora Cancer Care-Racine | Recruiting |
Racine, Wisconsin, United States, 53406 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Marshfield Medical Center-Rice Lake | Recruiting |
Rice Lake, Wisconsin, United States, 54868 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Michael Husak | |
Vince Lombardi Cancer Clinic-Sheboygan | Recruiting |
Sheboygan, Wisconsin, United States, 53081 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Marshfield Clinic Stevens Point Center | Recruiting |
Stevens Point, Wisconsin, United States, 54482 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Michael Husak | |
Aurora Medical Center in Summit | Recruiting |
Summit, Wisconsin, United States, 53066 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Vince Lombardi Cancer Clinic-Two Rivers | Recruiting |
Two Rivers, Wisconsin, United States, 54241 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
ProHealth Waukesha Memorial Hospital | Recruiting |
Waukesha, Wisconsin, United States, 53188 | |
Contact: Site Public Contact 262-928-7632 | |
Principal Investigator: Timothy R. Wassenaar | |
UW Cancer Center at ProHealth Care | Recruiting |
Waukesha, Wisconsin, United States, 53188 | |
Contact: Site Public Contact 262-928-5539 Chanda.miller@phci.org | |
Principal Investigator: Timothy R. Wassenaar | |
Aurora Cancer Care-Milwaukee West | Recruiting |
Wauwatosa, Wisconsin, United States, 53226 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora West Allis Medical Center | Recruiting |
West Allis, Wisconsin, United States, 53227 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Marshfield Medical Center - Weston | Recruiting |
Weston, Wisconsin, United States, 54476 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Michael Husak | |
United States, Wyoming | |
Billings Clinic-Cody | Recruiting |
Cody, Wyoming, United States, 82414 | |
Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
Principal Investigator: John M. Schallenkamp | |
Welch Cancer Center | Recruiting |
Sheridan, Wyoming, United States, 82801 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Puerto Rico | |
Pan American Center for Oncology Trials LLC | Recruiting |
San Juan, Puerto Rico, 00902 | |
Contact: Site Public Contact 787-407-3333 marcia.cruzcorrea@panoncologytrials.com | |
Principal Investigator: Marcia R. Cruz-Correa |
Principal Investigator: | Andrea B Apolo | Alliance for Clinical Trials in Oncology |
Responsible Party: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT03866382 |
Other Study ID Numbers: |
NCI-2019-01266 NCI-2019-01266 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) ) A031702 ( Other Identifier: Alliance for Clinical Trials in Oncology ) A031702 ( Other Identifier: CTEP ) U10CA180821 ( U.S. NIH Grant/Contract ) |
First Posted: | March 7, 2019 Key Record Dates |
Last Update Posted: | April 19, 2021 |
Last Verified: | April 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page |
URL: | https://grants.nih.gov/policy/sharing.htm |
Studies a U.S. FDA-regulated Drug Product: | Yes |
Studies a U.S. FDA-regulated Device Product: | No |
Carcinoma Neoplasms Prostatic Neoplasms Carcinoma, Squamous Cell Adenocarcinoma Urinary Bladder Neoplasms Carcinoma, Renal Cell Carcinoma, Transitional Cell Carcinoma, Neuroendocrine Urethral Neoplasms Adenocarcinoma, Clear Cell Carcinoma, Medullary Thyroid Neoplasms Penile Neoplasms Carcinoma, Small Cell |
Leydig Cell Tumor Sertoli Cell Tumor Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Genital Neoplasms, Male Urogenital Neoplasms Neoplasms by Site Prostatic Diseases Neoplasms, Squamous Cell Urologic Neoplasms Urinary Bladder Diseases Urologic Diseases Kidney Neoplasms Kidney Diseases Neuroendocrine Tumors |